Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 12/20 | 0.71 |
| ▸ | FLT1 | P17948 | 10/20 | 0.71 |
| ▸ | FLT4 | P35916 | 9/20 | 0.71 |
| ▸ | VCP | P55072 | 2/20 | 0.60 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.51 |
| ▸ | PRKAB2 | O43741 | 2/20 | 0.50 |
| ▸ | SRC | P12931 | 2/20 | 0.50 |
| ▸ | FLT3 | P36888 | 2/20 | 0.50 |
| ▸ | PRKAG1 | P54619 | 2/20 | 0.50 |
| ▸ | PRKAA2 | P54646 | 2/20 | 0.50 |
| ▸ | PRKAA1 | Q13131 | 2/20 | 0.50 |
| ▸ | MKNK1 | Q9BUB5 | 2/20 | 0.50 |
| ▸ | PRKAG3 | Q9UGI9 | 2/20 | 0.50 |
| ▸ | PRKAG2 | Q9UGJ0 | 2/20 | 0.50 |
| ▸ | PRKAB1 | Q9Y478 | 2/20 | 0.50 |
| ▸ | LCK | P06239 | 1/20 | 0.50 |
| ▸ | RPS6KA1 | Q15418 | 1/20 | 0.50 |
| ▸ | IMPDH2 | P12268 | 3/20 | 0.49 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gw572399X SCHEMBL31060985 | 0.83 | KDR (1.00) | KDRFLT1FLT4VCPROCK1 | |
| Gw549390X SCHEMBL3295009 | 0.79 | KDR (1.00) | KDRFLT1FLT4VCPROCK1 | |
| SCHEMBL5469435 | 0.78 | KDR (0.64) | KDRFLT1FLT4VCPROCK1 | |
| SCHEMBL5465153 | 0.77 | KDR (0.60) | KDRFLT1FLT4PRKAB2SRC | |
| SCHEMBL5186207 | 0.76 | KDR (0.68) | KDRFLT1FLT4VCPROCK1 | |
| SCHEMBL5186212 | 0.76 | KDR (0.61) | KDRFLT1FLT4VCPROCK1 | |
| SCHEMBL15878912 | 0.76 | KDR (0.79) | KDRFLT1FLT4VCPROCK1 | |
| SCHEMBL5465187 | 0.75 | KDR (0.79) | KDRFLT1FLT4 | |
| SCHEMBL5319681 | 0.73 | VCP (0.65) | KDRFLT1FLT4VCPROCK1 | |
| SCHEMBL5473057 | 0.73 | KDR (0.76) | KDRFLT1FLT4VCPIMPDH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050288515-A1 | Chemical compounds | SMITHLINE BEECHAM CORPORATION | 2005-12-29 | — | — | US | claimed |
| US-20070142437-A1 | CHEMICAL COMPOUNDS | BROWN MATTHEW L | 2007-06-21 | — | — | US | disclosed |
| US-20070142437-A1 | CHEMICAL COMPOUNDS | BROWN MATTHEW L | 2007-06-21 | — | — | US | disclosed |
| US-7189712-B2 | 1,3-Oxazole compounds for the treatment of cancer | SMITHKLINE BEECHAM CORPORATION (US) | 2007-03-13 | — | — | US | disclosed |
| US-7189712-B2 | 1,3-Oxazole compounds for the treatment of cancer | SMITHKLINE BEECHAM CORPORATION (US) | 2007-03-13 | — | — | US | disclosed |
| US-20050288515-A1 | Chemical compounds | SMITHLINE BEECHAM CORPORATION | 2005-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070142437-A1 | CHEMICAL COMPOUNDS | CDK4, CDK2, CDK3 | KDR 33/4885FLT1 56/4885FLT4 47/4885 |
| US-20050288515-A1 | Chemical compounds | CDK4, CDK2, CDK3 | KDR 33/4885FLT1 56/4885FLT4 47/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.